Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Mark A. Schubert"'
Autor:
Mark M. Schubert, Mark Clemons, William E. Barlow, Gabriel N. Hortobagyi, Jieling Miao, Elizabeth Claire Dees, James N. Ingle, Darya A. Kizub, Alexander H.G. Paterson, Julie R. Gralow, Carla I. Falkson
Publikováno v:
Support Care Cancer
PURPOSE: Bisphosphonates reduce bone metastases in postmenopausal women with early-stage breast cancer but carry the risk of bisphosphonate-related osteonecrosis of the jaw (BRONJ). We describe risk factors for BRONJ and compare BRONJ provoked by inf
Autor:
Mark Clemons, Jieling L M'iao, Jeffrey S. Abrams, Daniel F. Hayes, Helen K. Chew, J. Margolis, Elizabeth Claire Dees, Kim Z Dammann, Gabriel N. Hortobagyi, William E. Barlow, Catherine Van Poznak, Anthony D. Elias, Mark M. Schubert, Carla I. Falkson, Robert B. Livingston, Danika L. Lew, Shaker R. Dakhil, James N. Ingle, Michael J. Messino, Alexander H.G. Paterson, Dawn L. Hershman, Julie R. Gralow, Alison Stopeck
Publikováno v:
J Natl Cancer Inst
Background Adjuvant bisphosphonates, when given in a low-estrogen environment, can decrease breast cancer recurrence and death. Treatment guidelines include recommendations for adjuvant bisphosphonates in postmenopausal patients. SWOG/Alliance/Canadi
Publikováno v:
J Natl Cancer Inst Monogr
The increasing clinical indications for hematopoietic stem cell transplantation (HSCT) and improved clinical care throughout and following HSCT have led to not only long-term survival but also to an increasing incidence and prevalence of graft-versus
Autor:
N. Lynn Henry, Robert A. Bagramian, Mark M. Schubert, Amy K. Darke, Shaker R. Dakhil, Danika L. Lew, Catherine Van Poznak, James L. Wade, Dawn L. Hershman, Justin D. Floyd, Carol M. Moinpour, Michael J. Fisch, Joseph M. Unger, Lisa Hansen, Julie R. Gralow
Publikováno v:
JAMA Oncol
Importance Osteonecrosis of the jaw (ONJ) affects patients with cancer and metastatic bone disease (MBD) treated with bone-modifying agents (BMAs), yet the true incidence is unknown. Objective To define the cumulative incidence of ONJ at 3 years in p
Autor:
Raj G. Nair, Andrei Barasch, Marie Thérèse Genot, Judith A. E. M. Zecha, Judi N.A. van Diessen, Ron van der Brink, Liset Lansaat, Josep Arnabat-Domínguez, Mark M. Schubert, Lisette van der Molen, Irene Jacobi, Cesar A. Migliorati, Ludi E. Smeele, Michael R. Hamblin, Rene Jean Bensadoun, Joel B. Epstein, Judith E. Raber-Durlacher, Dan M.J. Milstein, Jan de Lange, Sharon Elad
Publikováno v:
Supportive Care in Cancer, 24(6), 2793-2805. Springer Verlag
Zecha, J A E M, Raber-Durlacher, J E, Nair, R G, Epstein, J B, Elad, S, Hamblin, M R, Barasch, A, Migliorati, C A, Milstein, D M J, Genot, M T, Lansaat, L, van der Brink, R, Arnabat-Dominguez, J, van Diessen, J, de Lange, J, Smeele, L E, Schubert, M M & Bensadoun, R J 2016, ' Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer. Part 2 : proposed applications and treatment protocols ', Supportive Care in Cancer, vol. 24, no. 6, pp. 2793-2805 . https://doi.org/10.1007/s00520-016-3153-y
Zecha, J A E M, Raber-Durlacher, J E, Nair, R G, Epstein, J B, Elad, S, Hamblin, M R, Barasch, A, Migliorati, C A, Milstein, D M J, Genot, M T, Lansaat, L, van der Brink, R, Arnabat-Dominguez, J, van Diessen, J, de Lange, J, Smeele, L E, Schubert, M M & Bensadoun, R J 2016, ' Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer. Part 2 : proposed applications and treatment protocols ', Supportive Care in Cancer, vol. 24, no. 6, pp. 2793-2805 . https://doi.org/10.1007/s00520-016-3153-y
Purpose There is a large body of evidence supporting the efficacy of low-level laser therapy (LLLT), more recently termed photobiomodulation (PBM) for the management of oral mucositis (OM) in patients undergoing radiotherapy for head and neck cancer
Autor:
Stephen T. Sonis, Josep Arnabat-Domínguez, Lisette van der Molen, Liset Lansaat, Jan de Lange, Sharon Elad, Irene Jacobi, Raj G. Nair, Judith A. E. M. Zecha, Judi N.A. van Diessen, Cesar A. Migliorati, Mark M. Schubert, René-Jean Bensadoun, Andrei Barasch, Michael R. Hamblin, Ron van der Brink, Marie-Thérèse Genot, Dan M.J. Milstein, Joel B. Epstein, Judith E. Raber-Durlacher, Ludi E. Smeele
Publikováno v:
Zecha, J A E M, Raber-Durlacher, J E, Nair, R G, Epstein, J B, Sonis, S T, Elad, S, Hamblin, M R, Barasch, A, Migliorati, C A, Milstein, D M J, Genot, M T, Lansaat, L, van der Brink, R, Arnabat-Dominguez, J, van Diessen, J, de Lange, J, Smeele, L E, Schubert, M M & Bensadoun, R J 2016, ' Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer. Part 1 : mechanisms of action, dosimetric, and safety considerations ', Supportive Care in Cancer, vol. 24, no. 6, pp. 2781-2792 . https://doi.org/10.1007/s00520-016-3152-z
Supportive Care in Cancer, 24(6), 2781-2792. Springer Verlag
Supportive Care in Cancer, 24(6), 2781-2792. Springer Verlag
PurposeThere is a large body of evidence supporting the efficacy of low level laser therapy (LLLT), more recently termed photobiomodulation (PBM), for the management of oral mucositis (OM) in patients undergoing radiotherapy for head and neck cancer
Publikováno v:
Thomas’ Hematopoietic Cell Transplantation
Autor:
Barry E. Storer, Marco Mielcarek, Sachiko Seo, Brenda M. Sandmaier, Marcello Rotta, Mark M. Schubert, Michael Boeckh
Publikováno v:
Bone Marrow Transplantation. 50:444-448
Recent studies have reported that statin use may be associated with improved outcomes in patients with sepsis or respiratory viral infections. In the setting of allogeneic hematopoietic cell transplantation (HCT), it has been shown that donor and rec
Autor:
Nicole M. A. Blijlevens, Michael T. Brennan, Mark M. Schubert, Judith E. Raber-Durlacher, Tuomas Waltimo, Elvira M. P. Correa, Sharon Elad, Siri Beier Jensen, Deborah P. Saunders, Noam Yarom, Nancy Mouradian, Joel B. Epstein, Yehuda Zadik
Publikováno v:
Supportive care in cancer, 23(6), 1615-1622. Springer Verlag
Supportive Care in Cancer, 23(6), 1615-1622. Springer Verlag
Elad, S, Jensen, S B, Raber-Durlacher, J E, Mouradian, N, Correa, E M P, Schubert, M M, Blijlevens, N M A, Epstein, J B, Saunders, D P, Waltimo, T, Yarom, N, Zadik, Y & Brennan, M T 2015, ' Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers ', Supportive Care in Cancer, vol. 23, no. 6, pp. 1615-1622 . https://doi.org/10.1007/s00520-014-2503-x
Supportive Care in Cancer, 23, 1615-22
Supportive Care in Cancer, 23, 6, pp. 1615-22
Supportive Care in Cancer, 23(6), 1615-1622. Springer Verlag
Elad, S, Jensen, S B, Raber-Durlacher, J E, Mouradian, N, Correa, E M P, Schubert, M M, Blijlevens, N M A, Epstein, J B, Saunders, D P, Waltimo, T, Yarom, N, Zadik, Y & Brennan, M T 2015, ' Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers ', Supportive Care in Cancer, vol. 23, no. 6, pp. 1615-1622 . https://doi.org/10.1007/s00520-014-2503-x
Supportive Care in Cancer, 23, 1615-22
Supportive Care in Cancer, 23, 6, pp. 1615-22
BackgroundThe oral cavity is frequently affected in chronic graft-versus-host disease (cGVHD), with variable clinical presentations. The literature on the effective management of patients suffering from oral cGVHD is limited.ObjectiveThe objective of
Autor:
Paula Charuhas Macris, Michele E. Lloid, Mark M. Schubert, Susan E. Coldwell, Rania Abasaeed, Sohaib H Soliman
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 26(10)
PURPOSE: to assess magnitude and characteristics of changes in chemosensory function and quality of life (QOL) for patients receiving hematopoietic stem cell transplantation (HSCT). METHODS: Patients (aged 18 years and above) scheduled to undergo HSC